Results 91 to 100 of about 61,579 (261)

Efetividade da proteína C reativa e da procalcitonina no diagnóstico de infecção e na predição de mortalidade em pacientes com cirrose hepática descompensada [PDF]

open access: yes, 2013
Dissertação (mestrado) - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde. Programa de Pós-graduação em Cuidados Intensivos e PaliativosIntrodução: Infecção bacteriana é uma complicação frequente nos pacientes com cirrose hepática ...
Lazzarotto, César
core  

Role of Gram‐Negative Bacterial Infections in Acute‐On‐Chronic Liver Failure

open access: yesLiver International, Volume 46, Issue 7, July 2026.
ABSTRACT Acute‐on‐chronic liver failure (ACLF) is a systemic disease characterised by an acute clinical deterioration of pre‐existing liver cirrhosis leading to multiple organ failure due to systemic inflammation. It may be triggered by the translocation of bacteria and bacterial compounds across the gut barrier.
Camilla Cadoli   +5 more
wiley   +1 more source

Procalcitonin as a Diagnostic and Monitoring Tool for Bacteraemia in Patients on Haemodialysis: A Systematic Review

open access: yesKidney and Dialysis
Background: Infections are a major cause of mortality in haemodialysis patients. The increasing antimicrobial resistance globally further exacerbates this concern.
Aniebiot-Abasi Udofia, Yiwei Zhang
doaj   +1 more source

La procalcitonina come indicatore di SIRS, sepsi e shock settico

open access: yesMicrobiologia Medica, 2004
Nosocomial infections are an important public health problem. Procalcitonin could be used as a clinical predictor of severe nosocomial infections. To validate procalcitonin as a diagnostic indicator of nosocomial infections, we have tested procalcitonin ...
Roberto Rossetti, Giacomo Corsini
doaj   +1 more source

Inflammatory Stewardship—A Perspective for Active Management of Acute Inflammation

open access: yesThe FASEB Journal, Volume 40, Issue 12, 30 June 2026.
Inflammatory stewardship frames inflammation as a manageable clinical domain requiring explicit strategy, governance, and feedback. It aligns diagnostics, risk stratification, biomarker interpretation, and immunomodulatory decisions across perioperative and critical‐care teams.
Lennart Finn Herrlich   +2 more
wiley   +1 more source

Factors Associated with Post-rewarming Procalcitonin Levels in Newborns with Hypoxic Ischemic Encephalopathy

open access: yes
Objective: To determine the factors associated with the procalcitonin levels in newborns with hypoxic-ischemic encephalopathy (HIE) who received therapeutic hypothermia (TH).
Aslı Okbay Güneş   +2 more
core   +1 more source

Giant cellulitis‐like Sweet's syndrome induced by gilteritinib

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Juan de Luque‐Fernández   +5 more
wiley   +1 more source

A Nano‐Interception Strategy for Chronic Heart Failure: Prussian Blue Nanoparticles Disrupt Fibroblast‐Immune Communication via CCL2 Sequestration

open access: yesAdvanced Materials, Volume 38, Issue 31, 2 June 2026.
A nano‐interception strategy disrupts pathogenic fibroblast–macrophage crosstalk in chronic heart failure. Scalable Prussian blue nanoparticles selectively sequester CCL2 via ultrahigh‐affinity binding, preventing CCR2+ macrophage recruitment and breaking a key fibro‐inflammatory circuit. This approach demonstrates robust efficacy in murine and porcine
Bo Chen   +16 more
wiley   +1 more source

Does serial procalcitonin monitoring predict clinical outcomes in children with sepsis? A diagnostic stewardship study

open access: yesAntimicrobial Stewardship & Healthcare Epidemiology
Objective: To determine if the initial procalcitonin level and the serial trend of procalcitonin levels in blood were predictive of clinical outcomes in children with sepsis.
Beenish Rubbab   +4 more
doaj   +3 more sources

Home - About - Disclaimer - Privacy